Brain natriuretic peptide levels in the obstructive sleep apnoea/hypopnoea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 355s Year: 2005
Vasopressin, atrial natriuretic peptide and adrenomedullin as markers of hypoxic stress in patients with obstructive sleep apnoea syndrome Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013
Obstructive sleep apnoea does not cause elevated plasma levels of N-terminal pro-brain natriuretic peptide Source: Eur Respir J 2005; 26: Suppl. 49, 38s Year: 2005
Association between obstructive sleep apnea and elevated levels of B-type natriuretic peptide in a community based sample of women Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
Pathophysiological consequences of obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006
Hepcidin: the new marker for determining nocturnal hypoxia in patients with obstructive sleep apnea Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
The expression of sleep apnea severity and central related sleep apnea in ECG-based cardiopulmonary coupling Source: Virtual Congress 2020 – Screening methods and diagnostic tools for obstructive sleep apnoea Year: 2020
Leptin in obstructive sleep apnea Source: Eur Respir J 2001; 18: Suppl. 33, 333s Year: 2001
NT-pro BNP is a marker for cardiovascular dysfunction due to obstructive sleep apnea syndrome Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010
Catecholamine secretion in obstructive sleep apnoea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 38s Year: 2005
Influence of adaptive servoventilation (ASV) on BNP in patients with Cheyne-Stokes respiration and central sleep apnea (CSR-CSA), with and without obstructive sleep apnea Source: Annual Congress 2008 - Outcome of adaptive servo ventilation in sleep apnoea Year: 2008
NT-proBNP in obstructive sleep apnoea (OSA) Source: Eur Respir J 2006; 28: Suppl. 50, 415s Year: 2006
Exercise responses in patients with sleep apnoea Source: Virtual Congress 2020 – Exercise and sleep: from impaired function to new therapeutic strategies Year: 2020
Pathophysiology of central sleep apnea Source: Annual Congress 2005 - Central sleep apnoea Year: 2005
Just sleep apnoea? Source: Breathe 2011; 7: 277-280 Year: 2011
Acetazolamide improves central sleep apnea in patients with obstructive sleep apnea syndrome at altitude Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009
Association between obstructive sleep apnea hypopnea and metabolic syndromes Source: Eur Respir J 2004; 24: Suppl. 48, 692s Year: 2004
Autonomic responses to apneas in relation with the severity of sleep apnea syndrome Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008
Cortisol metabolism in obstructive sleep apnea (OSA) Source: Eur Respir J 2002; 20: Suppl. 38, 215s Year: 2002
Targeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot study Source: Eur Respir J 2013; 41: 360-367 Year: 2013